申请人:Chaconne Nsi Co., Ltd.
公开号:US20020019389A1
公开(公告)日:2002-02-14
The present invention relates to a novel urea derivative represented by the following formula (I), which is useful as an anti-cancer agent:
1
its pharmaceutically acceptable acid addition salt or stereoisomer, in which X, Y, B and Het have the meaning as defined in the specification, and to a process for preparing the compound of formula (I) and an anti-cancer composition comprising the compound of formula (I) as an active ingredient.
本发明涉及一种新颖的尿素衍生物,其化学式如下(I),可用作抗癌剂:其药学上可接受的酸盐或立体异构体,其中X、Y、B和Het的含义如规范中所定义,并且涉及制备化合物的公式(I)以及包含公式(I)化合物作为活性成分的抗癌组合物的方法。